Drug intelligence / Profile preview

ALAnerv

Development stage
Unknown
Lead developer
Alfasigma
Modality
Small Molecules
Administration
Oral
01

Overview

ALAnerv is a multi-ingredient dietary supplement developed by Alfasigma (formerly Alfa Wassermann) specifically formulated to support the nervous system and manage oxidative stress. The product is primarily indicated for patients with peripheral neuropathies, including diabetic neuropathy and nerve compression syndromes such as carpal tunnel syndrome and sciatica. Its core component is **alpha-lipoic acid (ALA)**, a potent antioxidant that functions in both aqueous and lipid environments to neutralize free radicals and regenerate other antioxidants like Vitamin E. The formulation also includes **gamma-linolenic acid (GLA)**, an essential fatty acid that supports nerve cell membrane integrity and microcirculation. Additionally, ALAnerv contains a complex of B-group vitamins (B1, B2, B5, B6) to facilitate neuronal energy metabolism, alongside Vitamin E and selenium for enhanced antioxidant protection.

Brand names
ALAnervALAnerv ON
Other names
ALAnerv
02

Targets

PDH (Pyruvate dehydrogenase complex)OGDHC (2-oxoglutarate dehydrogenase complex)

Beyond the preview

Go deeper on ALAnerv.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALAnerv.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call